ARTICLE | Clinical News
Victoza liraglutide: Phase III data
November 1, 2010 7:00 AM UTC
A double-blind Phase III trial in 422 obese patients without diabetes who had already lost >=5% of their body weight during a 4-12 week run-in period on a low-calorie diet showed that patients receivi...